Research
Hormonal
An oral formulation of semaglutide (7 or 14 mg once daily) has been approved by the FDA for the treatment of type 2 diabetes.
Practitioners can consider the oral formulation of semaglutide as an option for managing type 2 diabetes.
StrongSupportsmedium confidence
An oral formulation of semaglutide (7 or 14 mg once daily) has been approved by the FDA for the treatment of type 2 diabetes.
Why this rating
The claim is based on FDA approval, indicating a high level of evidence.
Source
Next Chapter for Weight Control — Small-Molecule GLP-1 Receptor Agonists?
E. Dale Abel · New England Journal of Medicine · 2023
reviewCited 7×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →